首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >A New Herbal Formula KSG-002 Suppresses Breast Cancer Growth and Metastasis by Targeting NF-κB-Dependent TNFα Production in Macrophages
【2h】

A New Herbal Formula KSG-002 Suppresses Breast Cancer Growth and Metastasis by Targeting NF-κB-Dependent TNFα Production in Macrophages

机译:一种新的草药配方KSG-002通过靶向巨噬细胞中NF-κB依赖性TNFα的产生来抑制乳腺癌的生长和转移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tumor-associated macrophages (TAMs) in tumor microenvironment regulate cancer progression and metastases. In breast cancer, macrophage infiltration is correlated with a poor prognosis. While metastatic breast cancer is poor prognostic with a severe mortality, therapeutic options are still limited. In this study, we demonstrate that KSG-002, a new herbal composition of radices Astragalus membranaceus and Angelica gigas, suppresses breast cancer via inhibiting TAM recruitment. KSG-002, an extract of radices Astragalus membranaceus and Angelica gigas at 3 : 1 ratio, respectively, inhibited MDA-MB-231 xenograft tumor growth and pulmonary metastasis in nude mice, while KSG-001, another composition (1 : 1 ratio, w/w), enhanced tumor growth, angiogenesis, and pulmonary metastasis, in vivo. KSG-002 further decreased the infiltrated macrophage numbers in xenograft tumor cohorts. In Raw264.7 cells, KSG-002 but not KSG-001 inhibited cell proliferation and migration and reduced TNF-alpha (TNFα) production by inhibiting NF-κB pathway. Furthermore, a combinatorial treatment of KSG-002 with TNFα inhibited a proliferation and migration of both MDA-MB-231 and Raw264.7 cells. Taken together, we conclude that KSG-002 suppresses breast cancer growth and metastasis through targeting NF-κB-mediated TNFα production in macrophages.
机译:肿瘤微环境中的肿瘤相关巨噬细胞(TAM)调节癌症的进展和转移。在乳腺癌中,巨噬细胞浸润与不良预后相关。尽管转移性乳腺癌的预后较差,死亡率很高,但治疗选择仍然有限。在这项研究中,我们证明了KSG-002是一种新的草药成分,其成分为黄芪和当归,可通过抑制TAM募集来抑制乳腺癌。 KSG-002分别以3:1的比例提取黄芪和当归的骨提取物,可抑制MDA-MB-231裸鼠异种移植瘤的生长和肺转移,而另一种成分KSG-001(1:1的比例, w / w),可增强体内的肿瘤生长,血管生成和肺转移。 KSG-002进一步减少了异种移植肿瘤队列中浸润的巨噬细胞数量。在Raw264.7细胞中,KSG-002而非KSG-001抑制细胞增殖和迁移,并通过抑制NF-κB途径降低TNF-α(TNFα)的产生。此外,用TNFα组合治疗KSG-002可抑制MDA-MB-231和Raw264.7细胞的增殖和迁移。两者合计,我们得出结论,KSG-002通过靶向巨噬细胞中的NF-κB介导的TNFα产生来抑制乳腺癌的生长和转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号